LungenClinic Grosshansdorf

Recent papers from LungenClinic Grosshansdorf

1. ENTRÉE Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung CancerClinical Cancer Research · 2026
2. Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLCNew England Journal of Medicine · 2026
3. Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung CancerTargeted Oncology · 2026
4. Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trialThe Lancet · 2025
5. Nivolumab plus relatlimab with platinum-doublet chemotherapy versus nivolumab with platinum-doublet chemotherapy in stage IV or recurrent non-small cell lung cancer: clinical, translational, and patient-reported outcomes results from the phase II RELATIVITY-104 studyAnnals of Oncology · 2026
6. Dupilumab Efficacy on Exacerbations and Lung Function by Cough and Sputum Score: Pooled Results from Phase 3 BOREAS and NOTUSERJ Open Research · 2026
7. Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLCNature Medicine · 2026
8. Nasal Epithelial Immune Signatures Are Associated With Age‐Dependent Asthma Trajectories in Early LifeAllergy · 2026
9. Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation?Cancer Drug Resistance · 2026
10. Atezolizumab plus chemotherapy for Asian vs. non-Asian patients with extensive-stage small-cell lung cancer: A propensity score matched pooled analysis of four phase 3 trialsLung Cancer · 2026
11. Three Spirometry‐Based At‐Risk Phenotypes Predict Incident Airflow Limitation: A Population‐Based StudyRespirology · 2026
12. SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung CancerJournal of Clinical Oncology · 2026
13. Increased high sensitivity C-reactive protein in more severe wheeze/asthma phenotypes in child- and adulthood in ALLIANCERespiratory Research · 2026
14. Defining and validating a high specificity MRI cut-off for the radiographic part of the modified New York criteria in patients with axial spondyloarthritisArthritis Research & Therapy · 2026
15. Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315)Cancers · 2026
16. An individualized patient decision-making tool to improve decision making in non-small cell lung cancer: a mixed methods approachESMO Real World Data and Digital Oncology · 2026
17. Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung CancerJAMA Oncology · 2026
18. Carbon Input and Tillage Intensity Modulate Pedo‐Climatic Controls of Topsoil but Not Subsoil Physical PropertiesSoil Use and Management · 2026
19. Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancerJournal for ImmunoTherapy of Cancer · 2026
20. Frequency and Clinical Relevance of Residual Bronchodilator Responsiveness in Adults With AsthmaThe Journal of Allergy and Clinical Immunology In Practice · 2026